1
|
Gu C, Fan X, Yu W. Functional Diversity of Mammalian Small Heat Shock Proteins: A Review. Cells 2023; 12:1947. [PMID: 37566026 PMCID: PMC10417760 DOI: 10.3390/cells12151947] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2023] [Revised: 07/22/2023] [Accepted: 07/24/2023] [Indexed: 08/12/2023] Open
Abstract
The small heat shock proteins (sHSPs), whose molecular weight ranges from 12∼43 kDa, are members of the heat shock protein (HSP) family that are widely found in all organisms. As intracellular stress resistance molecules, sHSPs play an important role in maintaining the homeostasis of the intracellular environment under various stressful conditions. A total of 10 sHSPs have been identified in mammals, sharing conserved α-crystal domains combined with variable N-terminal and C-terminal regions. Unlike large-molecular-weight HSP, sHSPs prevent substrate protein aggregation through an ATP-independent mechanism. In addition to chaperone activity, sHSPs were also shown to suppress apoptosis, ferroptosis, and senescence, promote autophagy, regulate cytoskeletal dynamics, maintain membrane stability, control the direction of cellular differentiation, modulate angiogenesis, and spermatogenesis, as well as attenuate the inflammatory response and reduce oxidative damage. Phosphorylation is the most significant post-translational modification of sHSPs and is usually an indicator of their activation. Furthermore, abnormalities in sHSPs often lead to aggregation of substrate proteins and dysfunction of client proteins, resulting in disease. This paper reviews the various biological functions of sHSPs in mammals, emphasizing the roles of different sHSPs in specific cellular activities. In addition, we discuss the effect of phosphorylation on the function of sHSPs and the association between sHSPs and disease.
Collapse
Affiliation(s)
- Chaoguang Gu
- Institute of Biochemistry, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Xiasha High-Tech Zone No.2 Road, Hangzhou 310018, China;
| | - Xinyi Fan
- Faculty of Arts and Science, University of Toronto, Toronto, ON M5S1A1, Canada;
| | - Wei Yu
- Institute of Biochemistry, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Xiasha High-Tech Zone No.2 Road, Hangzhou 310018, China;
| |
Collapse
|
2
|
A Simplified and Effective Approach for the Isolation of Small Pluripotent Stem Cells Derived from Human Peripheral Blood. Biomedicines 2023; 11:biomedicines11030787. [PMID: 36979766 PMCID: PMC10045871 DOI: 10.3390/biomedicines11030787] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2023] [Revised: 02/24/2023] [Accepted: 03/03/2023] [Indexed: 03/08/2023] Open
Abstract
Pluripotent stem cells are key players in regenerative medicine. Embryonic pluripotent stem cells, despite their significant advantages, are associated with limitations such as their inadequate availability and the ethical dilemmas in their isolation and clinical use. The discovery of very small embryonic-like (VSEL) stem cells addressed the aforementioned limitations, but their isolation technique remains a challenge due to their small cell size and their efficiency in isolation. Here, we report a simplified and effective approach for the isolation of small pluripotent stem cells derived from human peripheral blood. Our approach results in a high yield of small blood stem cell (SBSC) population, which expresses pluripotent embryonic markers (e.g., Nanog, SSEA-3) and the Yamanaka factors. Further, a fraction of SBSCs also co-express hematopoietic markers (e.g., CD45 and CD90) and/or mesenchymal markers (e.g., CD29, CD105 and PTH1R), suggesting a mixed stem cell population. Finally, quantitative proteomic profiling reveals that SBSCs contain various stem cell markers (CD9, ITGA6, MAPK1, MTHFD1, STAT3, HSPB1, HSPA4), and Transcription reg complex factors (e.g., STAT5B, PDLIM1, ANXA2, ATF6, CAMK1). In conclusion, we present a novel, simplified and effective isolating process that yields an abundant population of small-sized cells with characteristics of pluripotency from human peripheral blood.
Collapse
|
3
|
Irani D, Balasinor N, Bansal V, Tandon D, Patil A, Singh D. Whole genome bisulfite sequencing of sperm reveals differentially methylated regions in male partners of idiopathic recurrent pregnancy loss cases. Fertil Steril 2023; 119:420-432. [PMID: 36528109 DOI: 10.1016/j.fertnstert.2022.12.017] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2022] [Revised: 12/04/2022] [Accepted: 12/07/2022] [Indexed: 12/15/2022]
Abstract
OBJECTIVE To study the genome wide alterations in sperm DNA methylation in male partners of idiopathic recurrent pregnancy loss (iRPL) cases and note regions as potential diagnostic markers. DESIGN Case-control study and methylome analysis of human sperm. SETTING Obstetrics and Gynaecology clinics. PATIENT(S) Control group consists of apparently healthy fertile men having fathered a child within the last 2 years (n = 39); and case group consists of male partners of iRPL cases having ≥2 consecutive 1st trimester pregnancy losses (n = 47). INTERVENTION(S) None. MAIN OUTCOME MEASURE(S) Sperm DNA samples of controls and cases were selected for whole genome bisulfite sequencing analysis based on the previously set thresholds of global methylation levels and methylation levels of imprinted genes (KvDMR and ZAC). Whole genome bisulfite sequencing of selected sperm genomic DNA was performed to identify differentially methylated CpG sites of iRPL cases compared with fertile controls. Pathway analysis of all the differentially methylated genes was done by Database for Annotation, Visualization, and Integrated Discovery annotation tool and Kyoto Encyclopedia of Genes and Genomes tool. Differentially methylated CpGs within genes relevant to embryo and placenta development were selected to further validate their methylation levels in study population by pyrosequencing. RESULT(S) A total of 9497 differentially methylated CpGs with highest enrichment in intronic regions were obtained. In addition, 5352 differentially methylated regions and 2087 differentially methylated genes were noted. Signaling pathways involved in development were enriched on pathway analysis. Select CpGs within genes PPARG, KCNQ1, SETD2, and MAP3K4 showed distinct hypomethylated subpopulations within iRPL study population. CONCLUSION(S) Our study highlights the altered methylation landscape of iRPL sperm, and their possible implications in pathways of embryo and placental development. The CpG sites that are hypomethylated specifically in sperm of iRPL subpopulation can be further assessed as predictive biomarkers.
Collapse
Affiliation(s)
- Delna Irani
- Department of Neuroendocrinology, ICMR - National Institute for Research in Reproductive and Child Health, Mumbai, India
| | - Nafisa Balasinor
- Department of Neuroendocrinology, ICMR - National Institute for Research in Reproductive and Child Health, Mumbai, India
| | - Vandana Bansal
- Department of Obstetrics and Gynaecology, Nowrosjee Wadia Maternity Hospital, Mumbai, India
| | - Deepti Tandon
- Department of Clinical Research, ICMR - National Institute for Research in Reproductive and Child Health, Mumbai, India
| | - Anushree Patil
- Department of Clinical Research, ICMR - National Institute for Research in Reproductive and Child Health, Mumbai, India
| | - Dipty Singh
- Department of Neuroendocrinology, ICMR - National Institute for Research in Reproductive and Child Health, Mumbai, India.
| |
Collapse
|
4
|
Johansen S, Traynor S, Ebstrup ML, Terp MG, Pedersen CB, Ditzel HJ, Gjerstorff MF. ZBED1 Regulates Genes Important for Multiple Biological Processes of the Placenta. Genes (Basel) 2022; 13:genes13010133. [PMID: 35052473 PMCID: PMC8775481 DOI: 10.3390/genes13010133] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2021] [Revised: 01/04/2022] [Accepted: 01/11/2022] [Indexed: 02/05/2023] Open
Abstract
The transcription factor ZBED1 is highly expressed in trophoblast cells, but its functions in the processes of trophoblast and placental biology remain elusive. Here, we characterized the role of ZBED1 in trophoblast cell differentiation using an in vitro BeWo cell model. We demonstrate that ZBED1 is enhanced in its expression early after forskolin-induced differentiation of BeWo cells and regulates many of the genes that are differentially expressed as an effect of forskolin treatment. Specifically, genes encoding markers for the differentiation of cytotrophoblast into syncytiotrophoblast and factors essential for trophoblast cell fusion and invasion were negatively regulated by ZBED1, indicating that ZBED1 might be important for maintaining a steady pool of cytotrophoblast cells. In addition, ZBED1 affected genes involved in the regulation of trophoblast cell survival and apoptosis, in agreement with the observed increase in apoptosis upon knockdown of ZBED1 in forskolin-treated BeWo cells. In addition, genes implicated in the differentiation, recruitment, and function of innate immune cells by the placenta were affected by ZBED1, further suggesting a role for this protein in the regulation of maternal immune tolerance. In conclusion, our study implicates ZBED1 in major biological processes of placental biology.
Collapse
Affiliation(s)
- Simone Johansen
- Department of Cancer and Inflammation Research, Institute for Molecular Medicine, University of Southern Denmark, 5000 Odense, Denmark; (S.J.); (S.T.); (M.L.E.); (M.G.T.); (C.B.P.); (H.J.D.)
| | - Sofie Traynor
- Department of Cancer and Inflammation Research, Institute for Molecular Medicine, University of Southern Denmark, 5000 Odense, Denmark; (S.J.); (S.T.); (M.L.E.); (M.G.T.); (C.B.P.); (H.J.D.)
| | - Malene Laage Ebstrup
- Department of Cancer and Inflammation Research, Institute for Molecular Medicine, University of Southern Denmark, 5000 Odense, Denmark; (S.J.); (S.T.); (M.L.E.); (M.G.T.); (C.B.P.); (H.J.D.)
| | - Mikkel Green Terp
- Department of Cancer and Inflammation Research, Institute for Molecular Medicine, University of Southern Denmark, 5000 Odense, Denmark; (S.J.); (S.T.); (M.L.E.); (M.G.T.); (C.B.P.); (H.J.D.)
| | - Christina Bøg Pedersen
- Department of Cancer and Inflammation Research, Institute for Molecular Medicine, University of Southern Denmark, 5000 Odense, Denmark; (S.J.); (S.T.); (M.L.E.); (M.G.T.); (C.B.P.); (H.J.D.)
| | - Henrik Jørn Ditzel
- Department of Cancer and Inflammation Research, Institute for Molecular Medicine, University of Southern Denmark, 5000 Odense, Denmark; (S.J.); (S.T.); (M.L.E.); (M.G.T.); (C.B.P.); (H.J.D.)
- Department of Oncology, Odense University Hospital, 5230 Odense, Denmark
- Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, 5230 Odense, Denmark
| | - Morten Frier Gjerstorff
- Department of Cancer and Inflammation Research, Institute for Molecular Medicine, University of Southern Denmark, 5000 Odense, Denmark; (S.J.); (S.T.); (M.L.E.); (M.G.T.); (C.B.P.); (H.J.D.)
- Department of Oncology, Odense University Hospital, 5230 Odense, Denmark
- Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, 5230 Odense, Denmark
- Correspondence: ; Tel.: +45-2126-1563
| |
Collapse
|
5
|
Seabrook JL, Cantlon JD, Cooney AJ, McWhorter EE, Fromme BA, Bouma GJ, Anthony RV, Winger QA. Role of LIN28A in mouse and human trophoblast cell differentiation. Biol Reprod 2013; 89:95. [PMID: 24006280 DOI: 10.1095/biolreprod.113.109868] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022] Open
Abstract
Proper regulation of trophoblast proliferation, differentiation, and function are critical for placenta development and function. The RNA-binding protein, LIN28A, has been well characterized as a potent regulator of differentiation in embryonic stem cells; however, little is known about the function of LIN28A in the placenta. We assessed LIN28A in vitro using mouse trophoblast stem (mTS) cells and human trophoblast cells (ACH-3P). We observed that LIN28A decreased and let-7 miRNA increased when mTS cells were induced to differentiate into mouse trophoblast giant cells (mTGCs) upon the removal of FGF4, heparin and conditioned medium. Similarly, we observed that LIN28A decreased in ACH-3P cells induced to syncytialize with forskolin treatment. To assess LIN28A in vivo we examined Embryonic Day 11.5 mouse placenta and observed abundant LIN28A in the chorioallantoic interface and labyrinth layer, with little LIN28A staining in spongiotrophoblast or differentiated mTGCs. Additionally, shRNA-mediated LIN28A knockdown in ACH-3P cells resulted in increased spontaneous syncytialization, and increased levels of syncytiotrophoblast markers hCG, LGALS13, and ERVW-1 mRNA. Additionally, targeted degradation of LIN28A mRNA increased responsiveness to forskolin-induced differentiation. In contrast, targeted degradation of Lin28a mRNA in mTS cells did not alter cell phenotype when maintained under proliferative culture conditions. Together, these data establish that LIN28A has a functional role in regulating trophoblast differentiation and function, and that loss of LIN28A in human trophoblast is sufficient to induce differentiation, but does not induce differentiation in the mouse.
Collapse
Affiliation(s)
- Jill L Seabrook
- Department of Biomedical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado
| | | | | | | | | | | | | | | |
Collapse
|
6
|
Market Velker BA, Denomme MM, Mann MR. Loss of genomic imprinting in mouse embryos with fast rates of preimplantation development in culture. Biol Reprod 2012; 86:143, 1-16. [PMID: 22278980 PMCID: PMC4480067 DOI: 10.1095/biolreprod.111.096602] [Citation(s) in RCA: 55] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2011] [Revised: 10/27/2011] [Accepted: 01/16/2012] [Indexed: 12/12/2022] Open
Abstract
Currently, the stage of embryo development has been proposed as one of many criteria for identifying healthy embryos in infertility clinics with the fastest embryos being highlighted as the healthiest. However the validity of this as an accurate criterion with respect to genomic imprinting is unknown. Given that embryo development in culture generally requires an extra day compared to in vivo development, we hypothesized that loss of imprinting correlates with slower rates of embryonic development. To evaluate this, embryos were recovered at the 2-cell stage, separated into four groups based on morphological stage at two predetermined time points, and cultured to blastocysts. We examined cell number, embryo volume, embryo sex, imprinted Snrpn and H19 methylation, imprinted Snrpn, H19, and Cdkn1c expression, and expression of genes involved in embryo metabolism-Atp1a1, Slc2a1, and Mapk14-all within the same individual embryo. Contrary to our hypothesis, we observed that faster developing embryos exhibited greater cell numbers and embryo volumes as well as greater perturbations in genomic imprinting and metabolic marker expression. Embryos with slower rates of preimplantation development were most similar to in vivo derived embryos, displaying similar cell numbers, embryo volumes, Snrpn and H19 imprinted methylation, H19 imprinted expression, and Atp1a1 and Slc2a1 expression. We conclude that faster development rates in vitro are correlated with loss of genomic imprinting and aberrant metabolic marker expression. Importantly, we identified a subset of in vitro cultured embryos that, according to the parameters evaluated, are very similar to in vivo derived embryos and thus are likely most suitable for embryo transfer.
Collapse
Affiliation(s)
- Brenna A. Market Velker
- Departments of Obstetrics & Gynecology, and Biochemistry, University of Western Ontario, Schulich School of Medicine and Dentistry, London, Ontario, Canada
- Children's Health Research Institute, London, Ontario, Canada
| | - Michelle M. Denomme
- Departments of Obstetrics & Gynecology, and Biochemistry, University of Western Ontario, Schulich School of Medicine and Dentistry, London, Ontario, Canada
- Children's Health Research Institute, London, Ontario, Canada
| | - Mellissa R.W. Mann
- Departments of Obstetrics & Gynecology, and Biochemistry, University of Western Ontario, Schulich School of Medicine and Dentistry, London, Ontario, Canada
- Children's Health Research Institute, London, Ontario, Canada
| |
Collapse
|
7
|
Fan GC. Role of heat shock proteins in stem cell behavior. PROGRESS IN MOLECULAR BIOLOGY AND TRANSLATIONAL SCIENCE 2012; 111:305-22. [PMID: 22917237 DOI: 10.1016/b978-0-12-398459-3.00014-9] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
Stress response is well appreciated to induce the expression of heat shock proteins (Hsps) in the cell. Numerous studies have demonstrated that Hsps function as molecular chaperones in the stabilization of intracellular proteins, repairing damaged proteins, and assisting in protein translocation. Various kinds of stem cells (embryonic stem cells, adult stem cells, or induced pluripotent stem cells) have to maintain their stemness and, under certain circumstances, undergo stress. Therefore, Hsps should have an important influence on stem cells. Actually, numerous studies have indicated that some Hsps physically interact with a number of transcription factors as well as intrinsic and extrinsic signaling pathways. Importantly, alterations in Hsp expression have been demonstrated to affect stem cell behavior including self-renewal, differentiation, sensitivity to environmental stress, and aging. This chapter summarizes recent findings related to (1) the roles of Hsps in maintenance of stem cell dormancy, proliferation, and differentiation; (2) the expression signature of Hsps in embryonic/adult stem cells and differentiated stem cells; (3) the protective roles of Hsps in transplanted stem cells; and (4) the possible roles of Hsps in stem cell aging.
Collapse
Affiliation(s)
- Guo-Chang Fan
- Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
| |
Collapse
|
8
|
Rupik W, Jasik K, Bembenek J, Widłak W. The expression patterns of heat shock genes and proteins and their role during vertebrate's development. Comp Biochem Physiol A Mol Integr Physiol 2011; 159:349-66. [DOI: 10.1016/j.cbpa.2011.04.002] [Citation(s) in RCA: 59] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2011] [Revised: 04/02/2011] [Accepted: 04/04/2011] [Indexed: 02/07/2023]
|
9
|
Loureiro B, Block J, Favoreto MG, Carambula S, Pennington KA, Ealy AD, Hansen PJ. Consequences of conceptus exposure to colony-stimulating factor 2 on survival, elongation, interferon-τ secretion, and gene expression. Reproduction 2011; 141:617-24. [PMID: 21339286 DOI: 10.1530/rep-10-0511] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Exposure of bovine conceptuses to colony-stimulating factor 2 (CSF2) from days 5 to 7 of development can increase the percentage of transferred conceptuses that develop to term. The purpose of this experiment was to understand the mechanism by which CSF2 increases embryonic and fetal survival. Conceptuses were produced in vitro in the presence or absence of 10 ng/ml CSF2 from days 5 to 7 after insemination, transferred into cows, and flushed from the uterus at day 15 of pregnancy. There was a tendency (P=0.07) for the proportion of cows with a recovered conceptus to be greater for those receiving a CSF2-treated conceptus (35% for control versus 66% for CSF2). Antiviral activity in uterine flushings, a measure of the amount of interferon-τ (IFNT2) secreted by the conceptus, tended to be greater for cows receiving CSF2-treated conceptuses than for cows receiving control conceptuses. This difference approached significance when only cows with detectable antiviral activity were considered (P=0.07). In addition, CSF2 increased mRNA for IFNT2 (P=0.08) and keratin 18 (P<0.05) in extraembryonic membranes. Among a subset of filamentous conceptuses that were analyzed by microarray hybridization, there was no effect of CSF2 on gene expression in the embryonic disc or extraembryonic membranes. Results suggest that the increase in calving rate caused by CSF2 treatment involves, in part, more extensive development of extraembryonic membranes and capacity of the conceptus to secrete IFNT2 at day 15 of pregnancy.
Collapse
Affiliation(s)
- Barbara Loureiro
- Department of Animal Sciences and DH Barron Reproductive and Perinatal Biology Research Program, University of Florida, PO Box 110910, Gainesville, Florida 32611-0910, USA
| | | | | | | | | | | | | |
Collapse
|
10
|
Groebe K, Hayess K, Klemm-Manns M, Schwall G, Wozny W, Steemans M, Peters AK, Sastri C, Jaeckel P, Stegmann W, Zengerling H, Schöpf R, Poznanovic S, Stummann TC, Seiler A, Spielmann H, Schrattenholz A. Protein Biomarkers for in Vitro Testing of Embryotoxicity. J Proteome Res 2010; 9:5727-38. [DOI: 10.1021/pr100514e] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Karlfried Groebe
- ProteoSys AG, Carl-Zeiss.-Str. 51, D-55129 Mainz, Germany, Federal Institute for Risk Assessment, Center for Alternative Methods to Animal Experiments - ZEBET Diedersdorfer Weg 1, 12277 Berlin, Germany, Johnson & Johnson PRD, a division of Janssen Pharmaceutical, 2340 Beerse, Belgium, European Centre for the Validation of Alternative Methods (ECVAM) (IHCP, JRC), Via Fermi, 121020 Ispra, Italy
| | - Katrin Hayess
- ProteoSys AG, Carl-Zeiss.-Str. 51, D-55129 Mainz, Germany, Federal Institute for Risk Assessment, Center for Alternative Methods to Animal Experiments - ZEBET Diedersdorfer Weg 1, 12277 Berlin, Germany, Johnson & Johnson PRD, a division of Janssen Pharmaceutical, 2340 Beerse, Belgium, European Centre for the Validation of Alternative Methods (ECVAM) (IHCP, JRC), Via Fermi, 121020 Ispra, Italy
| | - Martina Klemm-Manns
- ProteoSys AG, Carl-Zeiss.-Str. 51, D-55129 Mainz, Germany, Federal Institute for Risk Assessment, Center for Alternative Methods to Animal Experiments - ZEBET Diedersdorfer Weg 1, 12277 Berlin, Germany, Johnson & Johnson PRD, a division of Janssen Pharmaceutical, 2340 Beerse, Belgium, European Centre for the Validation of Alternative Methods (ECVAM) (IHCP, JRC), Via Fermi, 121020 Ispra, Italy
| | - Gerhard Schwall
- ProteoSys AG, Carl-Zeiss.-Str. 51, D-55129 Mainz, Germany, Federal Institute for Risk Assessment, Center for Alternative Methods to Animal Experiments - ZEBET Diedersdorfer Weg 1, 12277 Berlin, Germany, Johnson & Johnson PRD, a division of Janssen Pharmaceutical, 2340 Beerse, Belgium, European Centre for the Validation of Alternative Methods (ECVAM) (IHCP, JRC), Via Fermi, 121020 Ispra, Italy
| | - Woijciech Wozny
- ProteoSys AG, Carl-Zeiss.-Str. 51, D-55129 Mainz, Germany, Federal Institute for Risk Assessment, Center for Alternative Methods to Animal Experiments - ZEBET Diedersdorfer Weg 1, 12277 Berlin, Germany, Johnson & Johnson PRD, a division of Janssen Pharmaceutical, 2340 Beerse, Belgium, European Centre for the Validation of Alternative Methods (ECVAM) (IHCP, JRC), Via Fermi, 121020 Ispra, Italy
| | - Margino Steemans
- ProteoSys AG, Carl-Zeiss.-Str. 51, D-55129 Mainz, Germany, Federal Institute for Risk Assessment, Center for Alternative Methods to Animal Experiments - ZEBET Diedersdorfer Weg 1, 12277 Berlin, Germany, Johnson & Johnson PRD, a division of Janssen Pharmaceutical, 2340 Beerse, Belgium, European Centre for the Validation of Alternative Methods (ECVAM) (IHCP, JRC), Via Fermi, 121020 Ispra, Italy
| | - Annelieke K. Peters
- ProteoSys AG, Carl-Zeiss.-Str. 51, D-55129 Mainz, Germany, Federal Institute for Risk Assessment, Center for Alternative Methods to Animal Experiments - ZEBET Diedersdorfer Weg 1, 12277 Berlin, Germany, Johnson & Johnson PRD, a division of Janssen Pharmaceutical, 2340 Beerse, Belgium, European Centre for the Validation of Alternative Methods (ECVAM) (IHCP, JRC), Via Fermi, 121020 Ispra, Italy
| | - Chaturvedala Sastri
- ProteoSys AG, Carl-Zeiss.-Str. 51, D-55129 Mainz, Germany, Federal Institute for Risk Assessment, Center for Alternative Methods to Animal Experiments - ZEBET Diedersdorfer Weg 1, 12277 Berlin, Germany, Johnson & Johnson PRD, a division of Janssen Pharmaceutical, 2340 Beerse, Belgium, European Centre for the Validation of Alternative Methods (ECVAM) (IHCP, JRC), Via Fermi, 121020 Ispra, Italy
| | - Petra Jaeckel
- ProteoSys AG, Carl-Zeiss.-Str. 51, D-55129 Mainz, Germany, Federal Institute for Risk Assessment, Center for Alternative Methods to Animal Experiments - ZEBET Diedersdorfer Weg 1, 12277 Berlin, Germany, Johnson & Johnson PRD, a division of Janssen Pharmaceutical, 2340 Beerse, Belgium, European Centre for the Validation of Alternative Methods (ECVAM) (IHCP, JRC), Via Fermi, 121020 Ispra, Italy
| | - Werner Stegmann
- ProteoSys AG, Carl-Zeiss.-Str. 51, D-55129 Mainz, Germany, Federal Institute for Risk Assessment, Center for Alternative Methods to Animal Experiments - ZEBET Diedersdorfer Weg 1, 12277 Berlin, Germany, Johnson & Johnson PRD, a division of Janssen Pharmaceutical, 2340 Beerse, Belgium, European Centre for the Validation of Alternative Methods (ECVAM) (IHCP, JRC), Via Fermi, 121020 Ispra, Italy
| | - Helmut Zengerling
- ProteoSys AG, Carl-Zeiss.-Str. 51, D-55129 Mainz, Germany, Federal Institute for Risk Assessment, Center for Alternative Methods to Animal Experiments - ZEBET Diedersdorfer Weg 1, 12277 Berlin, Germany, Johnson & Johnson PRD, a division of Janssen Pharmaceutical, 2340 Beerse, Belgium, European Centre for the Validation of Alternative Methods (ECVAM) (IHCP, JRC), Via Fermi, 121020 Ispra, Italy
| | - Rainer Schöpf
- ProteoSys AG, Carl-Zeiss.-Str. 51, D-55129 Mainz, Germany, Federal Institute for Risk Assessment, Center for Alternative Methods to Animal Experiments - ZEBET Diedersdorfer Weg 1, 12277 Berlin, Germany, Johnson & Johnson PRD, a division of Janssen Pharmaceutical, 2340 Beerse, Belgium, European Centre for the Validation of Alternative Methods (ECVAM) (IHCP, JRC), Via Fermi, 121020 Ispra, Italy
| | - Slobodan Poznanovic
- ProteoSys AG, Carl-Zeiss.-Str. 51, D-55129 Mainz, Germany, Federal Institute for Risk Assessment, Center for Alternative Methods to Animal Experiments - ZEBET Diedersdorfer Weg 1, 12277 Berlin, Germany, Johnson & Johnson PRD, a division of Janssen Pharmaceutical, 2340 Beerse, Belgium, European Centre for the Validation of Alternative Methods (ECVAM) (IHCP, JRC), Via Fermi, 121020 Ispra, Italy
| | - Tina C. Stummann
- ProteoSys AG, Carl-Zeiss.-Str. 51, D-55129 Mainz, Germany, Federal Institute for Risk Assessment, Center for Alternative Methods to Animal Experiments - ZEBET Diedersdorfer Weg 1, 12277 Berlin, Germany, Johnson & Johnson PRD, a division of Janssen Pharmaceutical, 2340 Beerse, Belgium, European Centre for the Validation of Alternative Methods (ECVAM) (IHCP, JRC), Via Fermi, 121020 Ispra, Italy
| | - Andrea Seiler
- ProteoSys AG, Carl-Zeiss.-Str. 51, D-55129 Mainz, Germany, Federal Institute for Risk Assessment, Center for Alternative Methods to Animal Experiments - ZEBET Diedersdorfer Weg 1, 12277 Berlin, Germany, Johnson & Johnson PRD, a division of Janssen Pharmaceutical, 2340 Beerse, Belgium, European Centre for the Validation of Alternative Methods (ECVAM) (IHCP, JRC), Via Fermi, 121020 Ispra, Italy
| | - Horst Spielmann
- ProteoSys AG, Carl-Zeiss.-Str. 51, D-55129 Mainz, Germany, Federal Institute for Risk Assessment, Center for Alternative Methods to Animal Experiments - ZEBET Diedersdorfer Weg 1, 12277 Berlin, Germany, Johnson & Johnson PRD, a division of Janssen Pharmaceutical, 2340 Beerse, Belgium, European Centre for the Validation of Alternative Methods (ECVAM) (IHCP, JRC), Via Fermi, 121020 Ispra, Italy
| | - André Schrattenholz
- ProteoSys AG, Carl-Zeiss.-Str. 51, D-55129 Mainz, Germany, Federal Institute for Risk Assessment, Center for Alternative Methods to Animal Experiments - ZEBET Diedersdorfer Weg 1, 12277 Berlin, Germany, Johnson & Johnson PRD, a division of Janssen Pharmaceutical, 2340 Beerse, Belgium, European Centre for the Validation of Alternative Methods (ECVAM) (IHCP, JRC), Via Fermi, 121020 Ispra, Italy
| |
Collapse
|
11
|
Odiatis C, Georgiades P. New insights for Ets2 function in trophoblast using lentivirus-mediated gene knockdown in trophoblast stem cells. Placenta 2010; 31:630-40. [PMID: 20569982 DOI: 10.1016/j.placenta.2010.05.001] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/09/2010] [Revised: 04/30/2010] [Accepted: 05/04/2010] [Indexed: 11/26/2022]
Abstract
Mouse trophoblast stem (TS) cells represent a unique in vitro system that provides an unlimited supply of TS cells for the study of trophoblast differentiation and TS cell self-renewal. Although the mouse transcription factor Ets2 is required for TS cell self-renewal, its role in this and in TS cell differentiation has not been explored fully, partly due to the early lethality of Ets2 null mice. To address this, we developed a novel lentivirus-based system that resulted in efficient Ets2 knockdown in the overwhelming majority of TS cells. This system enables functional studies in TS cells, especially for genes required for TS cell self-renewal because TS cell derivation using gene-knockout embryos for such genes depends on TS cell self-renewal. Using morphological/morphometric criteria and gene expression analysis, we show that the requirement for Ets2 in self-renewal of TS cells cultured in 'stem cell medium' (SCM) involves maintenance of the expression of genes that inhibit TS cell differentiation in SCM, such as Cdx2 and Esrrb, and preservation of the undifferentiated TS cell morphology. During TS cell differentiation caused by Cdx2/Esrrb downregulation, due to either Ets2 knockdown in SCM or culture in differentiation medium (DM), Ets2 is also required for the promotion of trophoblast giant cell (TGC) and junctional zone trophoblast (JZT) differentiation. This TGC differentiation involves Ets2-dependent expression of Hand1, a gene required for the differentiation of all TGC types. This study uncovers new roles for Ets2 in TS cell self-renewal and differentiation and demonstrates the usefulness of this lentivirus system for gene function studies in TS cells.
Collapse
Affiliation(s)
- C Odiatis
- Department of Biological Sciences, University of Cyprus, University Campus, Nicosia, Cyprus
| | | |
Collapse
|
12
|
Kostenko S, Moens U. Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology. Cell Mol Life Sci 2009; 66:3289-307. [PMID: 19593530 PMCID: PMC11115724 DOI: 10.1007/s00018-009-0086-3] [Citation(s) in RCA: 276] [Impact Index Per Article: 18.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2009] [Revised: 06/22/2009] [Accepted: 06/23/2009] [Indexed: 10/20/2022]
Abstract
The small heat shock protein Hsp27 or its murine homologue Hsp25 acts as an ATP-independent chaperone in protein folding, but is also implicated in architecture of the cytoskeleton, cell migration, metabolism, cell survival, growth/differentiation, mRNA stabilization, and tumor progression. A variety of stimuli induce phosphorylation of serine residues 15, 78, and 82 in Hsp27 and serines 15 and 86 in Hsp25. This post-translational modification affects some of the cellular functions of Hsp25/27. As a consequence of the functional importance of Hsp25/27 phosphorylation, aberrant Hsp27 phosphorylation has been linked to several clinical conditions. This review focuses on the different Hsp25/27 kinases and phosphatases that regulate the phosphorylation pattern of Hsp25/27, and discusses the recent findings of the biological implications of these phosphorylation events in physiological and pathological processes. Novel therapeutic strategies aimed at restoring anomalous Hsp27 phosphorylation in human diseases will be presented.
Collapse
Affiliation(s)
- Sergiy Kostenko
- Department of Microbiology and Virology, Faculty of Medicine, University of Tromsø, 9037 Tromsø, Norway
| | - Ugo Moens
- Department of Microbiology and Virology, Faculty of Medicine, University of Tromsø, 9037 Tromsø, Norway
| |
Collapse
|
13
|
El-Hashash AHK, Warburton D, Kimber SJ. Genes and signals regulating murine trophoblast cell development. Mech Dev 2009; 127:1-20. [PMID: 19755154 DOI: 10.1016/j.mod.2009.09.004] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2009] [Revised: 09/05/2009] [Accepted: 09/08/2009] [Indexed: 11/25/2022]
Abstract
A fundamental step in embryonic development is cell differentiation whereby highly specialised cell types are developed from a single undifferentiated, fertilised egg. One of the earliest lineages to form in the mammalian conceptus is the trophoblast, which contributes exclusively to the extraembryonic structures that form the placenta. Trophoblast giant cells (TGCs) in the rodent placenta form the outermost layer of the extraembryonic compartment, establish direct contact with maternal cells, and produce a number of pregnancy-specific cytokine hormones. Giant cells differentiate from proliferative trophoblasts as they exit the cell cycle and enter a genome-amplifying endocycle. Normal differentiation of secondary TGCs is a critical step toward the formation of the placenta and normal embryonic development. Trophoblast development is also of particular interest to the developmental biologist and immunobiologist, as these cells constitute the immediate cellular boundary between the embryonic and maternal tissues. Abnormalities in the development of secondary TGCs results in severe malfunction of the placenta. Herein we review new information that has been accumulated recently regarding the molecular and cellular regulation of trophoblast and placenta development. In particular, we discuss the molecular aspects of murine TGC differentiation. We also focus on the role of growth and transcription factors in TGC development.
Collapse
Affiliation(s)
- Ahmed H K El-Hashash
- Developmental Biology, Saban Research Institute, Children's Hospital Los Angeles, Keck School of Medicine of University of Southern California, Los Angeles, CA 90027, USA
| | | | | |
Collapse
|
14
|
Palasz AT, Breña PB, De la Fuente J, Gutiérrez-Adán A. The effect of different zwitterionic buffers and PBS used for out-of-incubator procedures during standard in vitro embryo production on development, morphology and gene expression of bovine embryos. Theriogenology 2009; 70:1461-70. [PMID: 18675448 DOI: 10.1016/j.theriogenology.2008.06.092] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2007] [Revised: 06/11/2008] [Accepted: 06/18/2008] [Indexed: 10/21/2022]
Abstract
The effect of the zwitterionic buffers HEPES, TES and MOPS and of PBS used for out-of-incubator procedures during standard in vitro embryo production on bovine oocytes and embryo development, morphology and on the expression patterns of eight selected genes: Fgf-4, Lama1, Ube2a, Gsta4, Il6, Sod1, Prss11 and Hspb1, was evaluated. All buffers were prepared at a concentration of 10 mM in TALP medium, with the exception of PBS. The total time of oocyte/embryo exposure to each buffer was approximately 41 min. The cleavage rates and number of embryos that developed to > or =8 cells at day 4 were no different among the buffers tested, however, more blastocysts developed at day 7, 8 and 9 in HEPES and MOPS treatments than in PBS and TES (P<0.05). No difference between buffers in total and apoptotic cell number was found. Except for Hspb1 and Ube2a genes, the levels of expression of the six remaining transcripts were higher in in vivo than in in vitro embryos irrespective of buffer used (P<0.05). In addition, higher expression of Hspb1 and lower expression of Ube2a and Lama1 were observed in PBS and TES than in MOPS and HEPES treatments (P<0.05). Expression of Fgf-4 and Gsta4 in the in vitro embryos was lower in PBS than in the remaining three buffers (P<0.05) and the level of expression of the Il6 gene was not affected by any buffer tested but was lower in in vitro than in in vivo derived embryos. Expression of both Sod1 and Prss11 genes in MOPS were at the level of the in vivo embryos. These results showed that the choice of buffer and short exposure time of approximately 41 min, affects mRNA expression of in vitro produced bovine embryos.
Collapse
Affiliation(s)
- A T Palasz
- Ministry of Science and Innovation, Department of Animal Reproduction, INIA, Madrid, Spain.
| | | | | | | |
Collapse
|
15
|
Chaerkady R, Kerr CL, Marimuthu A, Kelkar DS, Kashyap MK, Gucek M, Gearhart JD, Pandey A. Temporal analysis of neural differentiation using quantitative proteomics. J Proteome Res 2009; 8:1315-26. [PMID: 19173612 PMCID: PMC2693473 DOI: 10.1021/pr8006667] [Citation(s) in RCA: 44] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
The ability to derive neural progenitors, differentiated neurons and glial cells from human embryonic stem cells (hESCs) with high efficiency holds promise for a number of clinical applications. However, investigating the temporal events is crucial for defining the underlying mechanisms that drive this process of differentiation along different lineages. We carried out quantitative proteomic profiling using a multiplexed approach capable of analyzing eight different samples simultaneously to monitor the temporal dynamics of protein abundance as human embryonic stem cells differentiate into motor neurons or astrocytes. With this approach, a catalog of approximately 1200 proteins along with their relative quantitative expression patterns was generated. The differential expression of the large majority of these proteins has not previously been reported or studied in the context of neural differentiation. As expected, two of the widely used markers of pluripotency, alkaline phosphatase (ALPL) and LIN28, were found to be downregulated during differentiation, while S-100 and tenascin C were upregulated in astrocytes. Neurofilament 3 protein, doublecortin and CAM kinase-like 1 and nestin proteins were upregulated during motor neuron differentiation. We identified a number of proteins whose expression was largely confined to specific cell types, embryonic stem cells, embryoid bodies and differentiating motor neurons. For example, glycogen phosphorylase (PYGL) and fatty acid binding protein 5 (FABP5) were enriched in ESCs, while beta spectrin (SPTBN5) was highly expressed in embryoid bodies. Karyopherin, heat shock 27 kDa protein 1 and cellular retinoic acid binding protein 2 (CRABP2) were upregulated in differentiating motor neurons but were downregulated in mature motor neurons. We validated some of the novel markers of the differentiation process using immunoblotting and immunocytochemical labeling. To our knowledge, this is the first large-scale temporal proteomic profiling of human stem cell differentiation into neural cell types highlighting proteins with limited or undefined roles in neural fate.
Collapse
Affiliation(s)
- Raghothama Chaerkady
- Institute of Bioinformatics, International Technology Park, Bangalore, 560066, India
- McKusick-Nathans Institute of Genetic Medicine and Departments of Biological Chemistry, Baltimore, MD, 21205, USA
- To whom correspondence should be addressed. E-mail: and E-mail:
| | - Candace L. Kerr
- Institute for Cell Engineering, Department of Obstetrics and Gynecology, Baltimore, MD, 21205, USA
- To whom correspondence should be addressed. E-mail: and E-mail:
| | - Arivusudar Marimuthu
- Institute of Bioinformatics, International Technology Park, Bangalore, 560066, India
- McKusick-Nathans Institute of Genetic Medicine and Departments of Biological Chemistry, Baltimore, MD, 21205, USA
| | - Dhanashree S. Kelkar
- Institute of Bioinformatics, International Technology Park, Bangalore, 560066, India
| | - Manoj Kumar Kashyap
- Institute of Bioinformatics, International Technology Park, Bangalore, 560066, India
- McKusick-Nathans Institute of Genetic Medicine and Departments of Biological Chemistry, Baltimore, MD, 21205, USA
| | - Marjan Gucek
- Institute of Basic Biomedical Sciences, Baltimore, MD, 21205, USA
| | - John D. Gearhart
- Institute for Cell Engineering, Department of Obstetrics and Gynecology, Baltimore, MD, 21205, USA
| | - Akhilesh Pandey
- McKusick-Nathans Institute of Genetic Medicine and Departments of Biological Chemistry, Baltimore, MD, 21205, USA
- Department of Pathology and Oncology, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA
| |
Collapse
|